News and Insights

Pharmaceuticals and Medical Devices

The Numerof 2020 Global Medical Device Outlook

Infographic

As our Numerof 2020 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about adapting to pressures on price and demands for value. You’ll continue to engage in new and different ways with regulators, public and private payers, consumers, employers, health care delivery, physicians,…

The Numerof 2020 Global Pharma Outlook

Infographic

As our Numerof 2020 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about continuing to adapt to pressures on price and demands for value. This will create the need for changes in current roles and external relationships. You’ll continue to engage in new and different…

Big Pharma Needs a Better Business Model, Not More Legislation

Forbes

When the Trump administration dropped the drug rebate rule it introduced back in January – a rule that intended to prohibit pharmacy benefit managers (PBMs) from pocketing some of the rebates they should be passing along to patients – the decision sent shockwaves through the healthcare industry, particularly the pharma…

Design Principles for Value-Based Solutions

Hospitals and healthcare delivery systems are facing significant pressure to improve quality, reduce costs, and increase revenues.  As a result, they are putting pressure on medical device manufacturers for lower prices and better outcomes.  In addition, they’re introducing other restrictions – like reducing the number of suppliers, limiting physician access,…

Case Study: Building the Economic Case for a Novel Medical Device

Numerof Case Study

An early phase manufacturer developed an innovative medical device and was rapidly gaining market traction and generating impressive sales. Facing the growth of bundled and capitated payment plans, the company engaged Numerof to develop a compelling economic and clinical effectiveness case to support product sales, and improve the company’s valuation…